Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Zoryve

Active ingredient: Roflumilast

Current FDA records distinguish Zoryve cream and foam presentations containing roflumilast. Check both the dosage form and strength because the available presentations are not represented by one interchangeable description.

NEXT STEP

Choose the strength and pack

No ready-made options were found for this medicine. You can type the details in the form.

Continue to the form

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Zoryve used for?

Zoryve (roflumilast) is a phosphodiesterase 4 inhibitor indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older. Zoryve is indicated for topical use on the affected areas, once daily.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Zoryve identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordZoryve
Active ingredientRoflumilast
Dosage formCheck the pack record
Recorded options0
Directory areaDermatology

OFFICIAL RECORD SUMMARY

Product details checked against regulatory sources

Current FDA records distinguish Zoryve cream and foam presentations containing roflumilast. Check both the dosage form and strength because the available presentations are not represented by one interchangeable description.

  • Cream: 0.3% (3 mg/g), 0.15% (1.5 mg/g) and 0.05% (0.5 mg/g), in 60 g tubes
  • Foam: 0.3% roflumilast
  • No product-specific central EMA EPAR is cited here; check the relevant national register for an EU country

Presentations can differ by jurisdiction and authorisation. This list is not a use or dosing recommendation.

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

No ready-made option can be shown.

Do not guess a missing strength or pack; use the details on the prescription and medicine box.

SERVICE BOUNDARY

Information checking and independent enquiry support for Zoryve.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Zoryve

01What is Zoryve?

This directory record associates the brand name Zoryve with the active ingredient Roflumilast. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Zoryve strengths and packs are recorded?

No ready-made strength and pack option can currently be shown from the catalogue record. Do not guess missing details; use the prescription and medicine box.

03Who manufactures Zoryve?

No organisation name can currently be shown confidently from the catalogue record. Verify the manufacturer or marketing-authorisation holder on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Zoryve?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Zoryve, payment request, stock guarantee or binding offer.

06Can I buy Zoryve from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.